Kyle for Adam Mayer's questions to Nyxoah SA (NYXH) leadership • Q2 2025
Question
Kyle, on behalf of Adam Mayer at Piper Sandler, requested more detail on the commercial launch strategy, specifically the types of accounts being targeted first, and asked about the reimbursement process and timeline for securing coverage from major payers.
Answer
CEO Olivier Talman outlined a two-pronged strategy focused on high-volume hypoglossal neurostimulation implanting centers and developing strong physician referral networks. CFO John Landry explained the reimbursement strategy leverages the existing CPT code 64568. He anticipates receiving pre-authorization approvals during 2025, with broader payer coverage decisions more likely to materialize in 2026.